| 000 | 01851 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516024954.0 | ||
| 264 | 0 | _c20111128 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1432-1041 | ||
| 024 | 7 |
_a10.1007/s00228-011-0993-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Xiaoqing | |
| 245 | 0 | 0 |
_aImpact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cAug 2011 |
||
| 300 |
_a803-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenetic Association Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInterleukin-10 _xgenetics |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWang, Zhaowen | |
| 700 | 1 | _aFan, Junwei | |
| 700 | 1 | _aLiu, Gaolin | |
| 700 | 1 | _aPeng, Zhihai | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 67 _gno. 8 _gp. 803-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-011-0993-8 _zAvailable from publisher's website |
| 999 |
_c20634403 _d20634403 |
||